Phase II evaluation of adriamycin in human neoplasia

Cancer. 1973 Jul;32(1):1-8. doi: 10.1002/1097-0142(197307)32:1<1::aid-cncr2820320101>3.0.co;2-x.
No abstract available

MeSH terms

  • Breast Neoplasms / drug therapy
  • Carcinoma / drug therapy
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / therapeutic use*
  • Electrocardiography
  • Evaluation Studies as Topic
  • Female
  • Gastrointestinal Diseases / chemically induced
  • Heart Conduction System / drug effects
  • Heart Failure / chemically induced
  • Hematopoiesis / drug effects
  • Humans
  • Lymphoma / drug therapy
  • Male
  • Neoplasms / drug therapy*
  • Prognosis
  • Remission, Spontaneous
  • Sarcoma / drug therapy

Substances

  • Doxorubicin